Staff Services Student Enterprise

Technology

Choose from the technologies below or instantly access non-exclusive licensed technology developed by University of Edinburgh researchers on our Click-Thru Licensing site.


Header image: Syda Productions/stock.adobe.com

Filter our technology by topic:

Results:

Technology  
Antisense oligonucleotides for ALS
Novel treatment of neurodegenerative diseases with accompanying TDP-43 proteinopathy
Biotechnology
Medical technologies
Technology  
Cobalt oxide nanoparticles
An alternative vaccine adjuvant
Biotechnology
Vaccines
Technology  
Engineered reprogramming factors for iPSC generation
A series of engineered molecules that retain a highly specific ability to reprogram adult or fully differentiated cells into pluripotent stem cells only.
Biotechnology
Clinical sciences
Technology  
FaTTy – a foundational cell line for cellular agriculture
Animals & Agriculture
Biotechnology
Technology  
Identifying structurally stable peptides
A new method for diagnostics and therapeutics development
Biotechnology
Therapeutics
Vaccines
Technology  
Microfabrication method of flexible electrically conductive layers
A novel technique that allows the production of highly conductive micro-wrinkled layers on flexible substrates, that can be repeatedly deformed without loss of their electrical properties.
Biotechnology
Medical technologies
Technology  
Pressure sensors with wireless operation
A highly sensitive and flexible wireless device for detection of physiological pressure changes in a body.
Biotechnology
Data, AI & robotics
Medical technologies
Technology  
Small photosensitizers for photodynamic therapy
Ultra-small photosensitizer molecules enable precise, minimally invasive photodynamic therapy with exceptional sensitivity and selectivity.
Biotechnology
Clinical sciences
Medical technologies
Therapeutics
Technology  
Super resolution cell layering to produce tubular tissue
Biotechnology
Medical technologies
Technology  
Treatment for Acute Respiratory Distress Syndrome (ARDS)
ARDS is the leading cause of respiratory failure in ICU patients who require mechanical ventilation. Colony Stimulating Factor 1 (CSF-1) is proposed as an effective therapy for the treatment of ARDS.
Biotechnology
Medical technologies
Therapeutics